Andrew R. Blight
2011
In 2011, Andrew R. Blight earned a total compensation of $1.5M as Chief Scientific Officer at Acorda Therapeutics, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,714 |
|---|---|
| Option Awards | $674,585 |
| Salary | $355,733 |
| Stock Awards | $330,900 |
| Other | $7,350 |
| Total | $1,501,282 |
Blight received $674.6K in option awards, accounting for 45% of the total pay in 2011.
Blight also received $132.7K in non-equity incentive plan, $355.7K in salary, $330.9K in stock awards and $7.4K in other compensation.
Rankings
In 2011, Andrew R. Blight's compensation ranked 4,208th out of 10,747 executives tracked by ExecPay. In other words, Blight earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,208 out of 10,747 | 61st |
Division Manufacturing | 1,490 out of 3,960 | 62nd |
Major group Chemicals And Allied Products | 304 out of 1,033 | 71st |
Industry group Drugs | 178 out of 781 | 77th |
Industry Biological Products, Except Diagnostic Substances | 27 out of 157 | 83rd |
Source: SEC filing on April 25, 2014.
Blight's colleagues
We found five more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2011.
2011
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2011
Jane Wasman
Acorda Therapeutics
General Counsel
2011
Thomas Wessel
Acorda Therapeutics
Chief Medical Officer
2011
David Lawrence
Acorda Therapeutics
Chief Financial Officer
2011
Lauren Sabella
Acorda Therapeutics